申请人:Hoffmann-La Roche Inc.
公开号:US05753679A1
公开(公告)日:1998-05-19
Benzly-piperidine derivatives of formula I and their pharmaceutically acceptable salts are used in the control of psychotic disorders which are caused by damage to the dopamine system, especially schizophrenia. ##STR1## A is ##STR2## B is ##STR3## R.sup.1, R.sup.2 and R.sup.3 are independently hydrogen, amino, nitro, halogen, lower-alkly or lower-alkoxy. R.sup.4, R.sup.5 and R.sup.6 are independently hydrogen, nitro, halogen, lower-alkyl, lower-alkoxy, cyano, trifluoromethyl, amino, lower-alkylamino or di-lower-alkylamino. R.sup.7, R.sup.2 and R.sup.9 are independently hydrogen, amino or nitro.
公式I中的Benzly-piperidine衍生物及其药学上可接受的盐,用于控制由多巴胺系统损伤引起的精神疾病,尤其是精神分裂症。 ##STR1## 其中,A为##STR2## B为##STR3## R1、R2和R3独立地为氢、氨基、硝基、卤素、低烷基或低烷氧基。R4、R5和R6独立地为氢、硝基、卤素、低烷基、低烷氧基、氰基、三氟甲基、氨基、低烷基氨基或二低烷基氨基。R7、R2和R9独立地为氢、氨基或硝基。